Compare Twilio Inc (TWLO) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Twilio Inc vs GeneDx Holdings Corp — how do they compare? Twilio Inc trades at $256 (market cap $39.31B), while GeneDx Holdings Corp trades at $82.71 (market cap $2.44B). The key difference: Twilio Inc is far larger — about 16.1× GeneDx Holdings Corp's market cap, and Twilio Inc is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| TWLO | WGS | |
|---|---|---|
Market Cap | $39.31B | $2.44B |
Sector | Technology | Technology |
52-Week High | $255.95 | $167.51 |
52-Week Low | $95.23 | $34.51 |
Enterprise Value | $37.72B | $2.48B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Twilio (TWLO) trades at $247.64, down 0.97% on the day but near its 52-week high, with a bullish technical outlook supported by moving averages. The company reported strong Q2 2026 results, beating EPS estimates with $1.47 actual vs. $1.32 expected, and raised full-year revenue growth guidance to 18-18.5%. Fundamentals show improving profitability, with net income margin reaching 20.62% in 2026, and positive cash flow trends.
The outlook is positive due to accelerating revenue growth and robust free cash flow generation, but risks include high valuation multiples like a P/E of 35.35 and competitive pressures in cloud communications. Analyst consensus is strongly bullish with a $266.31 price target, suggesting potential upside from current levels.
GeneDx Holdings Corp (WGS) trades at $82.07, up 5.38% in the past 24 hours, with technical indicators showing a bullish trend. The stock beat Q2 2026 EPS estimates but reported negative net income margins. Recent news highlights product expansion and institutional buying interest, though class-action lawsuits pose near-term sentiment risks.
Outlook is mixed: strong analyst buy ratings (90.9%) and a $79.25 consensus target suggest upside, but high valuation multiples and persistent losses require caution. Key risks include profitability challenges and legal overhangs, while revenue growth and market positioning offer long-term potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Twilio Inc
Twilio Inc. is a cloud-based communication platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces, or APIs, and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.
Read more on TWLO →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
